Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Gastric Ulcers Market Report 2024

Gastric Ulcers Global Market Report 2025 – By Drug Class (Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes), By Diagnosis (Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Gastric Ulcers Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Gastric Ulcers Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Gastric Ulcers Market Definition

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach's inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum.

The main types of drug classes in gastric ulcers are proton pump inhibitors (PPI), h2 antagonists, antacids, antibiotics, cytoprotective agents, and others. Proton pump inhibitors (PPI) refer to a class of medications that reduce stomach acid production by inhibiting the proton pump enzyme in gastric cells. Medications that reduce stomach acid production. These ulcers can be diagnosed by stool tests, endoscopies, imaging tests, computed tomography (CT) scans, X-rays, blood tests, and others, and include various routes of administration such as oral, parenteral, and others. Several distribution channels include mainly hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used by various end-users such as hospitals, specialty clinics, homecare, and others.

Gastric Ulcers Market Segmentation

The gastric ulcers market covered in this report is segmented –

1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes

2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole

2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine

3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate

4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline

5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate

6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies

Gastric Ulcers Market Size and growth rate 2025 to 2029: Graph

Gastric Ulcers Market Size 2025 And Growth Rate

The gastric ulcers market size has grown strongly in recent years. It will grow from $4.29 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising prevalence of helicobacter pylori infections, increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), growing geriatric population globally, rising awareness campaigns for gastric ulcer prevention and increasing incidence of stress-related disorders.

Gastric Ulcers Market Growth Forecast

The gastric ulcers market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to improvements in diagnostic techniques, adoption of unhealthy dietary habits, advancements in treatment options, including proton pump inhibitors (PPIs), aging population contributing to higher disease burden and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include shift towards combination therapies for enhanced efficacy, growing preference for minimally invasive treatment procedures, integration of digital health solutions in disease management, rising demand for over-the-counter (OTC) ulcer medications and expansion of personalized medicine approaches in ulcer treatment.

Book your 30 minutes free consultation with our research experts

Contact Us

Gastric Ulcers Market Driver: Increasing Geriatric Population Fuels Gastric Ulcers Market Growth

The increasing geriatric population is expected to propel the growth of the gastric ulcers market going forward. The geriatric population refers to individuals typically aged 65 years and older, characterized by specific health considerations related to aging. The increase in the geriatric population is due to advancements in healthcare, leading to longer life expectancy and declining birth rates in many regions globally. Gastric ulcers are common in the geriatric population due to increased use of NSAIDs and decreased mucosal protection, often leading to higher risks of complications. For instance, in January 2024, according to the Population Reference Bureau (PRB), a US-based private non-profit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, this age group's proportion of the total population is anticipated to rise from 17% to 23%. This shift indicates a significant aging trend in the U.S. population. The projections highlight the increasing importance of addressing the needs of older adults in various sectors. Therefore, the increasing geriatric population is driving the growth of the gastric ulcers market.

Global Gastric Ulcers Market Major Players

Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC

Global Gastric Ulcers Market Trend: Advancements In Drug Delivery Systems For Enhanced Efficacy And Safety

Major companies operating in the gastric ulcer market are focusing on developing innovative products, such as new formulations of drugs, to enhance treatment efficacy and reduce side effects. New formulation drugs refer to medications that are developed with innovative combinations of active ingredients, delivery systems, or dosage forms to improve their effectiveness, safety, and patient compliance. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched Rabeprazole + Levosulpiride SR Capsules to provide enhanced relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively treating gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and gastric ulcers. This formulation not only reduces gastric acid secretion but also enhances gastric motility, providing comprehensive relief from symptoms like heartburn and indigestion.

Gastric Ulcers Market Merger And Acquisition: Dr. Reddy's Laboratories Partners With HK Inno.N. Corporation For Tegoprazan In Emerging Markets

In May 2022, Dr. Reddy's Laboratories, an India-based pharmaceutical company, partnered with HK Inno.N. Corporation to supply and commercialize HK Inno.N. Corporation's patented novel molecule Tegoprazan for gastrointestinal diseases in India and six key emerging markets. Under the partnership, HK Inno.N. will be responsible for manufacturing and supplying Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing, and sales in the licensed territories. HK Inno.N. Corporation is a South Korea-based pharmaceutical company that provides drugs related to gastric ulcers.

Regional Outlook For The Global Gastric Ulcers Market

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastric ulcers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastric Ulcers Market?

The gastric ulcers market consists of revenues earned by entities through barium swallow, H. pylori testing, and biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric ulcers market also includes sales of amoxicillin, clarithromycin, metronidazole, omeprazole, and lansoprazole. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gastric Ulcers Industry?

The gastric ulcers market research report is one of a series of new reports from The Business Research Company that provides gastric ulcers market statistics, including gastric ulcers industry global market size, regional shares, competitors with a gastric ulcers market share, detailed gastric ulcers market segments, market trends and opportunities, and any further data you may need to thrive in the gastric ulcers industry. This gastric ulcers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gastric Ulcers Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $4.54 billion
Revenue Forecast In 2034 $5.64 billion
Growth Rate CAGR of 5.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes
2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users Subsegments: 1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate
4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline
5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate 6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Gastric Ulcers Market Characteristics

    3. Gastric Ulcers Market Trends And Strategies

    4. Gastric Ulcers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Gastric Ulcers Growth Analysis And Strategic Analysis Framework

    5.1. Global Gastric Ulcers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Gastric Ulcers Market Growth Rate Analysis

    5.4. Global Gastric Ulcers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Gastric Ulcers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Gastric Ulcers Total Addressable Market (TAM)

    6. Gastric Ulcers Market Segmentation

    6.1. Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Proton Pump Inhibitors (PPI)

    H2 Antagonists

    Antacids

    Antibiotics

    Cytoprotective Agents

    Other Drug Classes

    6.2. Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Stool Test

    Endoscopy

    Imaging Tests

    Computed Tomography (CT) Scan

    X-ray

    Blood Tests

    Other Diagnosis

    6.3. Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Parenteral

    Other Route Of Administrations

    6.4. Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    Other Distribution Channels

    6.5. Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Specialty Clinics

    Homecare

    Other End Users

    6.6. Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Omeprazole

    Lansoprazole

    Pantoprazole

    Esomeprazole

    Rabeprazole

    6.7. Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ranitidine

    Famotidine

    Cimetidine

    Nizatidine

    6.8. Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Calcium Carbonate

    Magnesium Hydroxide

    Aluminum Hydroxide

    Sodium Bicarbonate

    6.9. Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Amoxicillin

    Clarithromycin

    Metronidazole

    Tetracycline

    6.10. Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Sucralfate

    Misoprostol

    Bismuth Subsalicylate

    6.11. Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Prostaglandin Analogues

    Prokinetic Agents

    Herbal And Alternative Medications

    Combination Therapies

    7. Gastric Ulcers Market Regional And Country Analysis

    7.1. Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Gastric Ulcers Market

    8.1. Asia-Pacific Gastric Ulcers Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Gastric Ulcers Market

    9.1. China Gastric Ulcers Market Overview

    9.2. China Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Gastric Ulcers Market

    10.1. India Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Gastric Ulcers Market

    11.1. Japan Gastric Ulcers Market Overview

    11.2. Japan Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Gastric Ulcers Market

    12.1. Australia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Gastric Ulcers Market

    13.1. Indonesia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Gastric Ulcers Market

    14.1. South Korea Gastric Ulcers Market Overview

    14.2. South Korea Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Gastric Ulcers Market

    15.1. Western Europe Gastric Ulcers Market Overview

    15.2. Western Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Gastric Ulcers Market

    16.1. UK Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Gastric Ulcers Market

    17.1. Germany Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Gastric Ulcers Market

    18.1. France Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Gastric Ulcers Market

    19.1. Italy Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Gastric Ulcers Market

    20.1. Spain Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Gastric Ulcers Market

    21.1. Eastern Europe Gastric Ulcers Market Overview

    21.2. Eastern Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Gastric Ulcers Market

    22.1. Russia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Gastric Ulcers Market

    23.1. North America Gastric Ulcers Market Overview

    23.2. North America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Gastric Ulcers Market

    24.1. USA Gastric Ulcers Market Overview

    24.2. USA Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Gastric Ulcers Market

    25.1. Canada Gastric Ulcers Market Overview

    25.2. Canada Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Gastric Ulcers Market

    26.1. South America Gastric Ulcers Market Overview

    26.2. South America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Gastric Ulcers Market

    27.1. Brazil Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Gastric Ulcers Market

    28.1. Middle East Gastric Ulcers Market Overview

    28.2. Middle East Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Gastric Ulcers Market

    29.1. Africa Gastric Ulcers Market Overview

    29.2. Africa Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Gastric Ulcers Market Competitive Landscape And Company Profiles

    30.1. Gastric Ulcers Market Competitive Landscape

    30.2. Gastric Ulcers Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

    31. Gastric Ulcers Market Other Major And Innovative Companies

    31.1. Abbott Laboratories

    31.2. Novartis AG

    31.3. GlaxoSmithKline plc

    31.4. Takeda Pharmaceutical Co. Ltd

    31.5. Amgen Inc.

    31.6. Boehringer Ingelheim

    31.7. Viatris Inc.

    31.8. Daiichi Sankyo Company Limited

    31.9. Eisai Co. Ltd

    31.10. Cadila Pharmaceuticals

    31.11. Dr. Reddy’s Laboratories Ltd.

    31.12. Hikma Pharmaceuticals PLC

    31.13. Lupin Limited

    31.14. Yuhan Corporation

    31.15. Daewoong Pharmaceutical Co. Ltd

    32. Global Gastric Ulcers Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Gastric Ulcers Market

    34. Recent Developments In The Gastric Ulcers Market

    35. Gastric Ulcers Market High Potential Countries, Segments and Strategies

    35.1 Gastric Ulcers Market In 2029 - Countries Offering Most New Opportunities

    35.2 Gastric Ulcers Market In 2029 - Segments Offering Most New Opportunities

    35.3 Gastric Ulcers Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Pfizer Inc. Financial Performance
  • Table 83: Merck & Co Inc. Financial Performance
  • Table 84: AbbVie Inc. Financial Performance
  • Table 85: Sanofi S.A. Financial Performance
  • Table 86: AstraZeneca plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Pfizer Inc. Financial Performance
  • Figure 83: Merck & Co Inc. Financial Performance
  • Figure 84: AbbVie Inc. Financial Performance
  • Figure 85: Sanofi S.A. Financial Performance
  • Figure 86: AstraZeneca plc Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

Gastric Cancer Drugs Global Market Report 2025 – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Specialty Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gastric Volvulus Treatment Global Market Report 2025 – By Type (Organo-Axial Volvulus, Mesentero-Axial Volvulus), By Treatment Type (Medication, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gastric Cancer Diagnostic Procedure Global Market Report 2025 – By Procedure Type (Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types ), By Symptom Type (Symptomatic, Asymptomatic), By Offering Type (Instruments, Reagents and Consumables, Services), By Body Fluid Type (Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid), By Disease Indication (Early Gastric Cancer, Advanced Gastric Cancer) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diabetic Foot Ulcer Treatment Global Market Report 2025 – By Treatment( Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Other Treatments), By Ulcer Type( Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers), By Grade( Grade 1, Grade 2, Grade 3, Grade 4, Grade 5), By End-User( Hospital, Ambulatory Surgery Centre, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Ulcerative Colitis Global Market Report 2025 – By Drug Type (Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types), By Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis), By Molecule Type (Biologics, Small Molecules), By Route of Administration (Oral, Injectables), By End-User (Hospital Pharmacies, Retail Pharmacies, Drug Store, Other End-User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diabetic Foot Ulcer Global Market Report 2025 – By Type (Advanced Wound Care Dressings, Biologics, Therapy Device), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuro-ischemic Ulcers), By End-User (Hospitals, Ambulatory Surgery Centers, Home Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode of Purchase (Prescription Drugs, Over The Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Gastric Cancer Drugs Market 2021 - By Type (Imatnib, Trastuzumab), By End-User (Hospitals, Clinics Cancer Specialty Centers), By Route Of Administration (Oral, Parental) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Gastric Ulcers market?

Gastric ulcers, also known as peptic ulcers, are open sores on the stomach's inner lining due to the corrosive action of stomach acid. They often cause burning stomach pain, indigestion, and discomfort. Gastric ulcers are usually caused by an imbalance between stomach acid, an enzyme called pepsin, and the protective mucosal barrier lining the stomach and duodenum. For further insights on the Gastric Ulcers market, request a sample here

How will the Gastric Ulcers market drivers and restraints affect the market dynamics? What forces will shape the Gastric Ulcers industry going forward?

The Gastric Ulcers market major growth driver - Increasing Geriatric Population Fuels Gastric Ulcers Market Growth. For further insights on the Gastric Ulcers market, request a sample here

What is the forecast market size or the forecast market value of the Gastric Ulcers market?

The Gastric Ulcers market size has grown strongly in recent years. The gastric ulcers market size has grown strongly in recent years. It will grow from $4.29 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rising prevalence of helicobacter pylori infections, increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), growing geriatric population globally, rising awareness campaigns for gastric ulcer prevention and increasing incidence of stress-related disorders. The gastric ulcers market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to improvements in diagnostic techniques, adoption of unhealthy dietary habits, advancements in treatment options, including proton pump inhibitors (PPIs), aging population contributing to higher disease burden and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include shift towards combination therapies for enhanced efficacy, growing preference for minimally invasive treatment procedures, integration of digital health solutions in disease management, rising demand for over-the-counter (OTC) ulcer medications and expansion of personalized medicine approaches in ulcer treatment. For further insights on the Gastric Ulcers market, request a sample here

How is the Gastric Ulcers market segmented?

The gastric ulcers market covered in this report is segmented –
1) By Drug Class: Proton Pump Inhibitors (PPI), H2 Antagonists, Antacids, Antibiotics, Cytoprotective Agents, Other Drug Classes
2) By Diagnosis: Stool Test, Endoscopy, Imaging Tests, Computed Tomography (CT) Scan, X-ray, Blood Tests, Other Diagnosis
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Pantoprazole, Esomeprazole, Rabeprazole
2) By H2 Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide, Sodium Bicarbonate
4) By Antibiotics: Amoxicillin, Clarithromycin, Metronidazole, Tetracycline
5) By Cytoprotective Agents: Sucralfate, Misoprostol, Bismuth Subsalicylate
6) By Other Drug Classes: Prostaglandin Analogues, Prokinetic Agents, Herbal And Alternative Medications, Combination Therapies For further insights on the Gastric Ulcers market, request a sample here

Which region has the largest share of the Gastric Ulcers market? What are the other regions covered in the report?

North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Gastric Ulcers market, request a sample here.

Who are the major players in the Gastric Ulcers market?

Major companies operating in the gastric ulcer market are focusing on developing innovative products, such as new formulations of drugs, to enhance treatment efficacy and reduce side effects. New formulation drugs refer to medications that are developed with innovative combinations of active ingredients, delivery systems, or dosage forms to improve their effectiveness, safety, and patient compliance. For instance, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched Rabeprazole + Levosulpiride SR Capsules to provide enhanced relief for conditions such as gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. These products combine a proton pump inhibitor and a prokinetic agent, effectively treating gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and gastric ulcers. This formulation not only reduces gastric acid secretion but also enhances gastric motility, providing comprehensive relief from symptoms like heartburn and indigestion.. For further insights on the Gastric Ulcers market, request a sample here.

What are the key trends in the Gastric Ulcers market?

Major trends in the Gastric Ulcers market include Advancements In Drug Delivery Systems For Enhanced Efficacy And Safety. For further insights on the Gastric Ulcers market, request a sample here.

What are the major opportunities in the Gastric Ulcers market? What are the strategies for the Gastric Ulcers market?

For detailed insights on the major opportunities and strategies in the Gastric Ulcers market, request a sample here.

How does the Gastric Ulcers market relate to the overall economy and other similar markets?

For detailed insights on Gastric Ulcers's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Gastric Ulcers industry?

For detailed insights on the mergers and acquisitions in the Gastric Ulcers industry, request a sample here.

What are the key dynamics influencing the Gastric Ulcers market growth? SWOT analysis of the Gastric Ulcers market.

For detailed insights on the key dynamics influencing the Gastric Ulcers market growth and SWOT analysis of the Gastric Ulcers industry, request a sample here.